BRIEF published on 05/17/2024 at 15:05, 6 months 3 days ago Protenus Recognized for Workplace Excellence in 2024 Employee Satisfaction Protenus Healthcare Analytics Workplace Excellence Great Place To Work Certification
PRESS RELEASE published on 05/17/2024 at 15:00, 6 months 3 days ago Protenus Earns Esteemed Workplace Honors for 2024 Protenus recognized as one of the 2024 Modern Healthcare Best Places to Work in Healthcare and a Great Place to Work® for the fifth year, highlighting commitment to employee well-being and workplace culture Healthcare Compliance Work-life Balance Protenus Great Place To Work® Employee-centric Culture
BRIEF published on 04/04/2024 at 16:05, 7 months 16 days ago Protenus Awarded Drug Diversion Software Solutions Agreement With Premier, Inc. Healthcare Compliance Protenus Premier Inc. Drug Diversion Prevention Surveillance Technology
PRESS RELEASE published on 04/04/2024 at 16:00, 7 months 16 days ago Protenus Awarded Drug Diversion Software Solutions Agreement With Premier, Inc. Protenus awarded national group purchasing agreement with Premier, Inc. for Drug Diversion Software Solutions, offering Premier members special pricing and terms for Protenus solution Healthcare Protenus Premier Inc. Drug Diversion Supplier Contract
BRIEF published on 04/02/2024 at 16:05, 7 months 18 days ago Protenus Secures Two Innovative Patents for Enhancing Healthcare Compliance Healthcare Compliance Protenus Patient Privacy Monitoring Technology Innovation U.S. Patents
PRESS RELEASE published on 04/02/2024 at 16:00, 7 months 18 days ago Protenus Granted Two New Patents for Healthcare Compliance Protenus expands patient privacy monitoring technology with new patents to help hospitals identify record breaches. CEO emphasizes AI-driven solutions for protecting patient data Protenus Healthcare Compliance Analytics Patient Privacy Monitoring New Patents Data Breach
BRIEF published on 03/26/2024 at 16:05, 7 months 25 days ago Protenus Granted Sixth Patent for Drug Diversion Surveillance Technology Artificial Intelligence Healthcare Compliance Protenus Drug Diversion Surveillance Patent Grant
PRESS RELEASE published on 03/26/2024 at 16:00, 7 months 25 days ago Protenus Granted Sixth Patent for Drug Diversion Surveillance Technology Protenus receives new patent (U.S. Patent No. 11,923,062) to enhance drug diversion surveillance technology for hospitals. CEO Nick Culbertson highlights benefits Healthcare Compliance Patent Analytics Platform Protenus Drug Diversion Surveillance
BRIEF published on 03/19/2024 at 15:05, 8 months 1 day ago 2024 Breach Barometer Report Shows Alarming Increase in Patient Record Breaches AI Technology Protenus Healthcare Data Breach Privacy Security Compliance Analytics
PRESS RELEASE published on 03/19/2024 at 15:00, 8 months 1 day ago 2024 Breach Barometer Report Reveals a Drastic Surge to 171M Patient Records Breached Last Year The latest Breach Barometer report highlights a 187% increase in patient record breaches in 2023, emphasizing the urgent need for enhanced healthcare privacy and security measures Data Security Breach Barometer Report Healthcare Privacy Patient Record Breaches Privacy Threats
Published on 11/21/2024 at 14:15, 18 minutes ago neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
Published on 11/21/2024 at 14:00, 33 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 33 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 33 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 14:16, 16 minutes ago EQS-Adhoc: LM PAY S.A. Announces Third Quarter 2024 Preliminary Results and Updated Guidance
Published on 11/21/2024 at 14:15, 18 minutes ago ZenaTech Signs Blue UAS and NDAA Compliant Supply Chain Partners to Sell to US Defense Branches and NATO Forces
Published on 11/21/2024 at 12:35, 1 hour 57 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 06:58, 7 hours 35 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 19 hours 13 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 48 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 48 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
